-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UzbOZkvJ5dQrJkyRBhEasFm1vAgxqjvj4VQrEg607j2j0xrwbyiTQr/OUEcUPXs9
 e7mxO3SJjRHsvLDpGVaUcg==

<SEC-DOCUMENT>0000950123-97-008310.txt : 19971007
<SEC-HEADER>0000950123-97-008310.hdr.sgml : 19971007
ACCESSION NUMBER:		0000950123-97-008310
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	19971001
ITEM INFORMATION:		
FILED AS OF DATE:		19971006
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OSI PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000729922
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133159796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		
		SEC FILE NUMBER:	000-15190
		FILM NUMBER:		97691095

	BUSINESS ADDRESS:	
		STREET 1:		106 CHARLES LINDBERGH BLVD
		CITY:			UNIONDALE
		STATE:			NY
		ZIP:			11553
		BUSINESS PHONE:		5162220023

	MAIL ADDRESS:	
		STREET 1:		106 CHARLES LINDBERGH BLVD
		CITY:			UNIONDALE
		STATE:			NY
		ZIP:			11553-3649

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENE SCIENCE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<DESCRIPTION>OSI PHARMACEUTICALS, INC.
<TEXT>

<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported):      October 1, 1997


                            OSI PHARMACEUTICALS, INC.
               (Exact Name of Registrant as Specified in Charter)


Delaware                               0-15190                        13-3159796
(State or other jurisdiction         (Commission                (I.R.S. Employer
of incorporation)                    File Number)            Identification No.)


106 Charles Lindbergh Blvd., Uniondale, NY                            11553
   (Address of Principal Executive Offices)                         (Zip Code)


Registrant's telephone number, including area code:   (516) 222-0023


                             Oncogene Science, Inc.
          (Former name or former address, if changed since last report)
<PAGE>   2
ITEM 5.     OTHER EVENTS

      Effective October 1, 1997, Oncogene Science, Inc. ("OSI") changed its name
to OSI Pharmaceuticals, Inc. This change was effected under Delaware law in
connection with the merger into OSI of one of its wholly owned subsidiaries. In
addition, effective October 1, 1997, OSI's Nasdaq National Market symbol was
changed to "OSIP."
<PAGE>   3
                                   SIGNATURES


      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                              OSI PHARMACEUTICALS, INC.


                              By: /s/ Robert L. Van Nostrand
                                  --------------------------------------------
                                      Robert L. Van Nostrand,
                                      Vice President, Chief Financial Officer,
                                      Secretary and Treasurer


Dated:  October 3, 1997
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----